Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The objectives of this study is to determine the safety, tolerability, pharmacokinetics and
pharmacodynamics of HMS5552 following multiple ascending doses in patients with type 2
diabetes mellitus.